STOCK TITAN

Salarius Pharmaceuticals, Inc. (SLRX) Net Income by Year

SLRX

Salarius Pharmaceuticals, Inc. reported $12.5M in net income in fiscal year 2025. This represents an increase of 124.4% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Salarius Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Net Income $12.5M
YoY +124.4%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SLRX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY22FY21FY20FY19FY18FY17FY16FY15
Net Income$12.5M+124.4%$5.6M-55.5%$12.5M+139.7%-$31.6M-147.6%-$12.8M-73.7%-$7.4M-6.0%-$6.9M-315.4%-$1.7M+95.2%-$34.4M+12.8%-$39.5M-35.5%-$29.1M

SLRX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'23Q3'23Q2'23
Net Income-$2.2M-30.1%N/A-$873K+10.1%-$958K+32.8%-$1.7M+0.3%N/A-$972K+60.2%-$1.4M+63.3%-$1.7M+67.9%N/A-$2.4M+83.0%-$3.9M+17.8%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Salarius Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Salarius Pharmaceuticals, Inc.'s net income in fiscal year 2025?

Salarius Pharmaceuticals, Inc. reported $12.5M in net income in fiscal year 2025.

How fast is Salarius Pharmaceuticals, Inc.'s net income growing?

Salarius Pharmaceuticals, Inc. (SLRX) net income rose by 124.4% year over year, from $5.6M to $12.5M in fiscal year 2025.

How has Salarius Pharmaceuticals, Inc.'s net income changed over the years?

Across the 11 fiscal years this page covers, Salarius Pharmaceuticals, Inc. (SLRX) net income went from -$29.1M in fiscal year 2015 to $12.5M in fiscal year 2025.

Salarius Pharmaceuticals, Inc. (SLRX) reported -$2.2M in net income in Q1 2026. This represents a decrease of 30.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Salarius Pharmaceuticals, Inc. (SLRX) reported on that line in every period on record.